Foresee Pharmaceuticals Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-883.15	-1,081	-1,036	-472.64	-569.27
Depreciation & Amortization	68.13	79.1	73.45	50.93	51.16
Other Amortization	-	1.42	0.18	0.22	0.32
Loss (Gain) From Sale of Assets	-	0.03	0.2	0.31	0.13
Asset Writedown & Restructuring Costs	-	-	-	1.16	-
Loss (Gain) From Sale of Investments	-	-	-	-0.29	-0.8
Stock-Based Compensation	33.69	49.82	50.77	40.18	23.92
Other Operating Activities	0.76	-3.68	0.5	0.69	-9.42
Change in Accounts Receivable	-11.16	33.58	-49.64	-16.27	-
Change in Inventory	39.17	-57.08	49.61	-151.53	40.1
Change in Accounts Payable	-47.85	52.29	-10.72	22.85	-
Change in Unearned Revenue	-50.03	-114.5	-1.01	-1.8	160.76
Change in Other Net Operating Assets	8.21	-133.67	35.41	-4.79	34.76
Operating Cash Flow	-842.23	-1,174	-887.56	-233.22	-213.33
Capital Expenditures	-2.96	-149.59	-46.28	-58.07	-6.86
Sale of Property, Plant & Equipment	-	0.21	0.23	-	-
Sale (Purchase) of Intangibles	-12.54	-6.36	-	-	-0.54
Investment in Securities	-145.7	267.5	-249	100	25
Other Investing Activities	-0.55	1.06	-1.03	-1.23	0.02
Investing Cash Flow	-161.75	112.82	-296.08	40.7	17.62
Short-Term Debt Issued	600	800	300	-	-
Long-Term Debt Issued	-	100	-	-	-
Total Debt Issued	600	900	300	-	-
Short-Term Debt Repaid	-553	-850	-100	-	-30.07
Long-Term Debt Repaid	-111.05	-17.09	-15.52	-11.35	-84.1
Total Debt Repaid	-664.05	-867.09	-115.52	-11.35	-114.17
Net Debt Issued (Repaid)	-64.05	32.91	184.48	-11.35	-114.17
Issuance of Common Stock	198.23	1,378	1,319	14.21	38.43
Financing Cash Flow	134.18	1,411	1,504	2.86	-75.74
Foreign Exchange Rate Adjustments	-17.99	8	-0.09	7.73	-2.23
Net Cash Flow	-887.78	357.62	320.17	-181.93	-273.68
Free Cash Flow	-845.19	-1,323	-933.84	-291.29	-220.19
Free Cash Flow Margin	-195.98%	-316.07%	-478.80%	-96.61%	-97.42%
Free Cash Flow Per Share	-5.46	-9.64	-7.34	-2.47	-1.88
Cash Interest Paid	5.62	6.47	2.68	0.4	0.76
Cash Income Tax Paid	25.23	51.71	46.01	29.01	41.66
Levered Free Cash Flow	-442.09	-753.85	-616.79	-402.03	-236.28
Unlevered Free Cash Flow	-438.61	-749.65	-615.01	-401.78	-235.85
Change in Working Capital	-61.66	-219.37	23.64	146.23	290.62

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.